Royal Bank of Canada’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-388
| Closed | – | – | 8130 |
|
|
2022
Q3 | $0 | Buy |
+388
| New | +$169 | ﹤0.01% | 8177 |
|
|
2022
Q2 | – | Sell |
-30
| Closed | – | – | 8113 |
|
|
2022
Q1 | $0 | Sell |
30
-2,591
| -99% | -$4.71K | ﹤0.01% | 8225 |
|
|
2021
Q4 | $5K | Buy |
+2,621
| New | +$6.28K | ﹤0.01% | 7249 |
|
|
2021
Q3 | – | Sell |
-16,172
| Closed | -$63K | – | 8058 |
|
|
2021
Q2 | $63K | Buy |
16,172
+12,337
| +322% | +$51.1K | ﹤0.01% | 5885 |
|
|
2021
Q1 | $19K | Buy |
3,835
+1,476
| +63% | +$7.66K | ﹤0.01% | 6466 |
|
|
2020
Q4 | $9K | Buy |
2,359
+2,308
| +4,525% | +$11.3K | ﹤0.01% | 6454 |
|
|
2020
Q3 | $0 | Buy |
+51
| New | +$279 | ﹤0.01% | 7098 |
|
|
2020
Q2 | – | Sell |
-24
| Closed | – | – | 7047 |
|
|
2020
Q1 | $0 | Buy |
24
+21
| +700% | +$111 | ﹤0.01% | 7173 |
|
|
2019
Q4 | $0 | Sell |
3
-36
| -92% | -$114 | ﹤0.01% | 7257 |
|
|
2019
Q3 | $0 | Buy |
+39
| New | +$141 | ﹤0.01% | 7299 |
|
|
2019
Q1 | – | Sell |
-1,465
| Closed | -$4K | – | 7227 |
|
|
2018
Q4 | $4K | Sell |
1,465
-37
| -2% | -$217 | ﹤0.01% | 6273 |
|
|
2018
Q3 | $11K | Buy |
1,502
+37
| +3% | +$162 | ﹤0.01% | 5959 |
|
|
2018
Q2 | $5K | Sell |
1,465
-489
| -25% | -$2.26K | ﹤0.01% | 6064 |
|
|
2018
Q1 | $8K | Sell |
1,954
-10
| -0.5% | -$42 | ﹤0.01% | 5807 |
|
|
2017
Q4 | $7K | Hold |
1,964
| – | – | ﹤0.01% | 6004 |
|
|
2017
Q3 | $8K | Sell |
1,964
-597
| -23% | -$2.74K | ﹤0.01% | 6337 |
|
|
2017
Q2 | $13K | Buy |
2,561
+1,931
| +307% | +$10.8K | ﹤0.01% | 5709 |
|
|
2017
Q1 | $4K | Sell |
630
-100
| -14% | -$781 | ﹤0.01% | 6305 |
|
|
2016
Q4 | $7K | Buy |
+730
| New | +$6.58K | ﹤0.01% | 6224 |
|
|
2016
Q3 | – | Sell |
-585
| Closed | -$8K | – | 6647 |
|
|
2016
Q2 | $8K | Sell |
585
-14,628
| -96% | -$228K | ﹤0.01% | 5822 |
|
|
2016
Q1 | $213K | Buy |
15,213
+15,209
| +380,225% | +$223K | ﹤0.01% | 4330 |
|
|
2015
Q4 | $0 | Sell |
4
-383
| -99% | -$5.91K | ﹤0.01% | 6896 |
|
|
2015
Q3 | $5K | Sell |
387
-282
| -42% | -$4.68K | ﹤0.01% | 6176 |
|
|
2015
Q2 | $10K | Buy |
+669
| New | +$12.8K | ﹤0.01% | 6058 |
|
|
2015
Q1 | – | Sell |
-59
| Closed | -$1K | – | 6484 |
|
|
2014
Q4 | $1K | Buy |
+59
| New | +$1.2K | ﹤0.01% | 6066 |
|
Royal Bank of Canada's AGTC Position: Q4 2022 in Review
Royal Bank of Canada sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 388 shares.
Royal Bank of Canada first reported a position in AGTC in Q4 2014 and held it in 25 quarters. The position peaked at $213K in Q1 2016. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Royal Bank of Canada reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Royal Bank of Canada sold 388 Applied Genetic Technologies Corporation shares in Q4 2022.
- Royal Bank of Canada first reported a position in Applied Genetic Technologies Corporation in Q4 2014 and held it in 25 quarters.
- Royal Bank of Canada's Applied Genetic Technologies Corporation position peaked at $213K in Q1 2016.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Royal Bank of Canada's 13F filing for Q4 2022, filed 14 Feb 2023.